vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.

Shoals Technologies Group, Inc. is the larger business by last-quarter revenue ($148.3M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). Shoals Technologies Group, Inc. runs the higher net margin — 5.5% vs -38.1%, a 43.5% gap on every dollar of revenue. On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs 20.2%). Over the past eight quarters, Shoals Technologies Group, Inc.'s revenue compounded faster (27.8% CAGR vs 24.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.

PRCT vs SHLS — Head-to-Head

Bigger by revenue
SHLS
SHLS
1.8× larger
SHLS
$148.3M
$83.1M
PRCT
Growing faster (revenue YoY)
SHLS
SHLS
+18.4% gap
SHLS
38.6%
20.2%
PRCT
Higher net margin
SHLS
SHLS
43.5% more per $
SHLS
5.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
SHLS
SHLS
Annualised
SHLS
27.8%
24.8%
PRCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
SHLS
SHLS
Revenue
$83.1M
$148.3M
Net Profit
$-31.6M
$8.1M
Gross Margin
64.9%
31.6%
Operating Margin
-4.1%
11.7%
Net Margin
-38.1%
5.5%
Revenue YoY
20.2%
38.6%
Net Profit YoY
-27.9%
3.9%
EPS (diluted)
$-0.56
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SHLS
SHLS
Q1 26
$83.1M
Q4 25
$76.4M
$148.3M
Q3 25
$83.3M
$135.8M
Q2 25
$79.2M
$110.8M
Q1 25
$69.2M
$80.4M
Q4 24
$68.2M
$107.0M
Q3 24
$58.4M
$102.2M
Q2 24
$53.4M
$99.2M
Net Profit
PRCT
PRCT
SHLS
SHLS
Q1 26
$-31.6M
Q4 25
$-29.8M
$8.1M
Q3 25
$-21.4M
$11.9M
Q2 25
$-19.6M
$13.9M
Q1 25
$-24.7M
$-282.0K
Q4 24
$-18.9M
$7.8M
Q3 24
$-21.0M
$-267.0K
Q2 24
$-25.6M
$11.8M
Gross Margin
PRCT
PRCT
SHLS
SHLS
Q1 26
64.9%
Q4 25
60.6%
31.6%
Q3 25
64.8%
37.0%
Q2 25
65.4%
37.2%
Q1 25
63.9%
35.0%
Q4 24
64.0%
37.6%
Q3 24
63.2%
24.8%
Q2 24
59.0%
40.3%
Operating Margin
PRCT
PRCT
SHLS
SHLS
Q1 26
-4.1%
Q4 25
-40.6%
11.7%
Q3 25
-27.8%
13.7%
Q2 25
-28.0%
14.4%
Q1 25
-39.7%
5.4%
Q4 24
-28.9%
15.4%
Q3 24
-38.4%
4.4%
Q2 24
-50.3%
18.7%
Net Margin
PRCT
PRCT
SHLS
SHLS
Q1 26
-38.1%
Q4 25
-39.1%
5.5%
Q3 25
-25.7%
8.7%
Q2 25
-24.7%
12.5%
Q1 25
-35.8%
-0.4%
Q4 24
-27.6%
7.3%
Q3 24
-35.9%
-0.3%
Q2 24
-48.0%
11.9%
EPS (diluted)
PRCT
PRCT
SHLS
SHLS
Q1 26
$-0.56
Q4 25
$-0.54
$0.05
Q3 25
$-0.38
$0.07
Q2 25
$-0.35
$0.08
Q1 25
$-0.45
$0.00
Q4 24
$-0.34
$0.04
Q3 24
$-0.40
$0.00
Q2 24
$-0.50
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SHLS
SHLS
Cash + ST InvestmentsLiquidity on hand
$245.6M
$7.3M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$600.0M
Total Assets
$487.1M
$904.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SHLS
SHLS
Q1 26
$245.6M
Q4 25
$286.5M
$7.3M
Q3 25
$294.3M
$8.6M
Q2 25
$302.7M
$4.7M
Q1 25
$316.2M
$35.6M
Q4 24
$333.7M
$23.5M
Q3 24
$196.8M
$11.1M
Q2 24
$214.1M
$3.2M
Total Debt
PRCT
PRCT
SHLS
SHLS
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
$141.8M
Q4 24
$51.5M
$141.8M
Q3 24
$51.4M
$141.8M
Q2 24
$51.4M
$146.8M
Stockholders' Equity
PRCT
PRCT
SHLS
SHLS
Q1 26
$347.7M
Q4 25
$365.9M
$600.0M
Q3 25
$380.3M
$589.6M
Q2 25
$385.8M
$575.4M
Q1 25
$389.2M
$558.9M
Q4 24
$402.2M
$556.8M
Q3 24
$241.2M
$545.2M
Q2 24
$251.8M
$544.6M
Total Assets
PRCT
PRCT
SHLS
SHLS
Q1 26
$487.1M
Q4 25
$508.1M
$904.1M
Q3 25
$511.5M
$851.8M
Q2 25
$513.1M
$795.0M
Q1 25
$519.4M
$788.4M
Q4 24
$534.0M
$793.1M
Q3 24
$374.1M
$801.3M
Q2 24
$374.4M
$788.4M
Debt / Equity
PRCT
PRCT
SHLS
SHLS
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
0.25×
Q4 24
0.13×
0.25×
Q3 24
0.21×
0.26×
Q2 24
0.20×
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SHLS
SHLS
Operating Cash FlowLast quarter
$-4.1M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-7.6%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$-16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SHLS
SHLS
Q1 26
Q4 25
$-10.3M
$-4.1M
Q3 25
$-6.6M
$19.4M
Q2 25
$-15.0M
$-13.8M
Q1 25
$-17.0M
$15.6M
Q4 24
$-32.4M
$14.0M
Q3 24
$-18.8M
$15.7M
Q2 24
$-15.7M
$37.8M
Free Cash Flow
PRCT
PRCT
SHLS
SHLS
Q1 26
Q4 25
$-12.2M
$-11.3M
Q3 25
$-9.5M
$9.0M
Q2 25
$-17.8M
$-26.0M
Q1 25
$-18.8M
$12.3M
Q4 24
$-33.6M
$12.5M
Q3 24
$-19.0M
$13.3M
Q2 24
$-16.8M
$35.8M
FCF Margin
PRCT
PRCT
SHLS
SHLS
Q1 26
Q4 25
-15.9%
-7.6%
Q3 25
-11.4%
6.6%
Q2 25
-22.5%
-23.5%
Q1 25
-27.2%
15.4%
Q4 24
-49.2%
11.6%
Q3 24
-32.6%
13.0%
Q2 24
-31.4%
36.1%
Capex Intensity
PRCT
PRCT
SHLS
SHLS
Q1 26
Q4 25
2.4%
4.8%
Q3 25
3.4%
7.7%
Q2 25
3.5%
11.0%
Q1 25
2.7%
4.0%
Q4 24
1.7%
1.4%
Q3 24
0.4%
2.3%
Q2 24
2.0%
2.0%
Cash Conversion
PRCT
PRCT
SHLS
SHLS
Q1 26
Q4 25
-0.50×
Q3 25
1.63×
Q2 25
-1.00×
Q1 25
Q4 24
1.79×
Q3 24
Q2 24
3.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SHLS
SHLS

System Solutions$122.0M82%
Components$26.3M18%

Related Comparisons